Dallas, Tx – May 2, 2017 – North American Cannabis Holdings, Inc. (USOTC: USMJ) today announced that the pilot sales of new sports and fitness nutritional supplements that resulted in the Company’s reported 40% revenue growth and 53% gross margin growth in Q2 continued into Q3 are expected to remain consistent in Q4. Management anticipates the upcoming Q3 financial report to reflect the continued pilot product sales.
“Last year, the Company introduced the pilot sales of some new sports and fitness nutritional supplements as part of our ongoing strategy to develop the AmeriCanna Cafe and a line of AmeriCanna Cafe cannabis infused products,” said Steven Rash, CEO of North American Cannabis Holdings. “As the word ‘pilot’ suggests, the sales of the nutritional supplements was a test. The test went better than anticipated and substantially boosted our overall sales revenue in our fiscal Q2. We are fortunate to have hit a new product line right out of the gate and not otherwise had to endure cycling through trial and error to get it right. At this point, we expect the increased sales to continue and we are now working to expand the sales program.”
Learn More About USMJ: growusmj.com
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
North American Cannabis Holdings Contact: